PEOPLE - Thermo Electron (US) makes appointments:
This article was originally published in Clinica
Executive Summary
Thermo Electron, a US provider of analytical and monitoring instruments, has strengthened its management team with the appointment of Kristina Isakovich as vice-president of corporate strategy (joining from Mckinsey & Company); Dr William Hancock, as division vice-president and director of proteomics in the life sciences sector (Hewlett-Packard/Agilent Laboratories); and Dr Christopher Becker, as director of proteomics technology from GenTrace Systems, a company he co-founded and which develops genomic and proteomic analytical systems based on high-throughput mass spectrometry.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.